GENFIT (EPA:GNFT) | Finanzwire

Basculer en Français

9475	Companies
185441	Keywords
117777	Articles
99294	Press releases

Home
Companies
GENFIT

BRIEF

published on 05/14/2025 at 22:15, 6 months 21 days ago

GENFIT Releases 2025 Extra-Financial Performance Report for 2024

Sustainability ESG Biopharmaceutical Corporate Responsibility GENFIT
PRESS RELEASE

published on 05/14/2025 at 22:10, 6 months 21 days ago

GENFIT: Publication of the 2025 Extra-Financial Performance Report (fiscal year 2024)
GENFIT publishes 2025 Extra-Financial Performance Report for fiscal year 2024. Focus on sustainability, ESG approach, social responsibility commitment, and liver disease research

Sustainability GENFIT ESG Approach 2025 Extra-Financial Performance Report Liver Disease Research
BRIEF

published on 05/07/2025 at 22:15, 6 months 28 days ago

GENFIT prepares its Combined General Meeting in June 2025

Biopharmaceuticals General Assembly Documentation GENFIT Online Voting
PRESS RELEASE

published on 05/07/2025 at 22:10, 6 months 28 days ago

GENFIT Annual Combined General Meeting of June 17, 2025 — Availability of Preparatory Documents
GENFIT announces Annual Combined General Meeting on June 17, 2025, providing shareholders with preparatory documents and online voting option. Company's focus on liver diseases and diverse R&D portfolio highlighted

Shareholders Annual Meeting Liver Diseases GENFIT R&D Portfolio
BRIEF

published on 05/05/2025 at 07:35, 7 months ago

GENFIT to Showcase ACLF Research at EASL Congress 2025

Biopharmaceutical GENFIT EASL Congress ACLF Research Hepatology
PRESS RELEASE

published on 05/05/2025 at 07:30, 7 months ago

GENFIT to Present Latest ACLF Research at EASL Congress 2025
GENFIT to Present Latest ACLF Research at EASL Congress 2025. Six posters on ACLF and diagnostic models. Events include EASL Studio and ACLF Patient Advocacy Council session

Research GENFIT ACLF EASL Congress Posters
BRIEF

published on 04/29/2025 at 21:15, 7 months 5 days ago

GENFIT Publishes its 2024 Annual Reports

Annual Report Biopharmaceuticals Registration Document Liver Diseases GENFIT
PRESS RELEASE

published on 04/29/2025 at 21:10, 7 months 5 days ago

GENFIT Announces Publication of the 2024 Universal Registration Document and the 2024 Annual Report on Form 20-F
GENFIT announces filing of 2024 Universal Registration Document and Annual Report on Form 20-F with AMF and SEC, available for public viewing and download. Details of reports and company's focus on liver disease research and development highlighted

2024 Universal Registration Document Form 20-F Liver Diseases GENFIT
BRIEF

published on 04/28/2025 at 22:15, 7 months 6 days ago

GENFIT's Positive Phase 2 Results for Elafibranor in PSC Announced

GENFIT Phase 2 Results Elafibranor PSC EASL Congress 2025
PRESS RELEASE

published on 04/28/2025 at 22:10, 7 months 6 days ago

GENFIT: positive late-breaking Phase 2 data for elafibranor in Primary Sclerosing Cholangitis (PSC) to be presented by Ipsen at EASL Congress 2025
GENFIT announces positive Phase 2 data for elafibranor in Primary Sclerosing Cholangitis (PSC) to be presented at EASL Congress 2025 by Ipsen, showing significant efficacy and safety profile improvements

GENFIT EASL Congress Elafibranor Phase 2 Data Primary Sclerosing Cholangitis

Accesswire

Published on 12/05/2025 at 02:35, 8 hours 10 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 8 hours 15 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 9 hours 45 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 11 hours 40 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 11 hours 45 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 10:30, 15 minutes ago

Tradegate Exchange and Börse Berlin merge to form Tradegate BSX
Published on 12/05/2025 at 10:15, 30 minutes ago

Wuxi’s Liangxi District: Where 3,000 Years of Jiangnan Culture Thrives
Published on 12/05/2025 at 09:40, 1 hour 5 minutes ago

Chery Partners with 2025 Asian Youth Para Games, Taking Center Stage in Global Sports with Passion and Aspiration
Published on 12/05/2025 at 09:30, 1 hour 15 minutes ago

REPLOID Group AG: Exhibitor at the BIOGAS Convention & Trade Fair in Nuremberg, Germany
Published on 12/05/2025 at 09:05, 1 hour 40 minutes ago

Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis

Les Echos

Published on 12/05/2025 at 08:45, 2 hours ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 16 hours 45 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 17 hours ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 17 hours 1 minute ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 3 hours ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

View all LES ECHOS COMFI WIRE